GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Functional Technologies Corp (TSXV:FEB.H) » Definitions » ROE %

Functional Technologies (TSXV:FEB.H) ROE % : -500.83% (As of Aug. 2012)


View and export this data going back to . Start your Free Trial

What is Functional Technologies ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Functional Technologies's annualized net income for the quarter that ended in Aug. 2012 was C$-12.64 Mil. Functional Technologies's average Total Stockholders Equity over the quarter that ended in Aug. 2012 was C$2.52 Mil. Therefore, Functional Technologies's annualized ROE % for the quarter that ended in Aug. 2012 was -500.83%.

The historical rank and industry rank for Functional Technologies's ROE % or its related term are showing as below:

TSXV:FEB.H's ROE % is not ranked *
in the Biotechnology industry.
Industry Median: -43.775
* Ranked among companies with meaningful ROE % only.

Functional Technologies ROE % Historical Data

The historical data trend for Functional Technologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Functional Technologies ROE % Chart

Functional Technologies Annual Data
Trend Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -70.63 -62.82 -59.87 -71.29 -500.83

Functional Technologies Semi-Annual Data
Aug01 Aug02 Aug03 Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.63 -62.82 -59.87 -71.29 -500.83

Competitive Comparison of Functional Technologies's ROE %

For the Biotechnology subindustry, Functional Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Functional Technologies's ROE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Functional Technologies's ROE % distribution charts can be found below:

* The bar in red indicates where Functional Technologies's ROE % falls into.



Functional Technologies ROE % Calculation

Functional Technologies's annualized ROE % for the fiscal year that ended in Aug. 2012 is calculated as

ROE %=Net Income (A: Aug. 2012 )/( (Total Stockholders Equity (A: Aug. 2011 )+Total Stockholders Equity (A: Aug. 2012 ))/ count )
=-12.636/( (8.469+-3.423)/ 2 )
=-12.636/2.523
=-500.83 %

Functional Technologies's annualized ROE % for the quarter that ended in Aug. 2012 is calculated as

ROE %=Net Income (Q: Aug. 2012 )/( (Total Stockholders Equity (Q: Aug. 2011 )+Total Stockholders Equity (Q: Aug. 2012 ))/ count )
=-12.636/( (8.469+-3.423)/ 2 )
=-12.636/2.523
=-500.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is one times the annual (Aug. 2012) net income data. ROE % is displayed in the 30-year financial page.


Functional Technologies  (TSXV:FEB.H) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Aug. 2012 )
=Net Income/Total Stockholders Equity
=-12.636/2.523
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-12.636 / 0.176)*(0.176 / 6.8665)*(6.8665 / 2.523)
=Net Margin %*Asset Turnover*Equity Multiplier
=-7179.55 %*0.0256*2.7216
=ROA %*Equity Multiplier
=-183.8 %*2.7216
=-500.83 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Aug. 2012 )
=Net Income/Total Stockholders Equity
=-12.636/2.523
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-12.636 / -12.636) * (-12.636 / -4.668) * (-4.668 / 0.176) * (0.176 / 6.8665) * (6.8665 / 2.523)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 2.7069 * -2652.27 % * 0.0256 * 2.7216
=-500.83 %

Note: The net income data used here is one times the annual (Aug. 2012) net income data. The Revenue data used here is one times the annual (Aug. 2012) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Functional Technologies ROE % Related Terms

Thank you for viewing the detailed overview of Functional Technologies's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Functional Technologies (TSXV:FEB.H) Business Description

Traded in Other Exchanges
N/A
Address
Functional Technologies Corp is incorporated under the corporate laws of British Columbia, Canada on October 18, 1999. The Company is a functional foods and biological health products company that is developing and commercializing advanced yeast products and other novel biological products for the food and health care industry. The company develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries, for which viable solutions are lacking. The Company's platform technologies improve the performance of innate yeast functions to primarily prevent the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by various global agencies as dangerous substances (e.g. carcinogens, neurotoxicants or reproductive toxicants). The Company operates in three geographic regions: Canada, Europe and the United States.

Functional Technologies (TSXV:FEB.H) Headlines

No Headlines